OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 68 filers reported holding OLEMA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $738 | -19.8% | 59,773 | -41.3% | 0.06% | -31.5% |
| Q2 2023 | $920 | +15.0% | 101,840 | -55.8% | 0.09% | +16.5% |
| Q1 2023 | $800 | +40.8% | 230,632 | -0.4% | 0.08% | +12.9% |
| Q4 2022 | $568 | -99.8% | 231,633 | +122.5% | 0.07% | +84.2% |
| Q3 2022 | $287,000 | -6.8% | 104,084 | +44.0% | 0.04% | -7.3% |
| Q1 2022 | $308,000 | -18.3% | 72,287 | +79.7% | 0.04% | -12.8% |
| Q4 2021 | $377,000 | – | 40,227 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 7,803,600 | $96,374,460 | 6.54% |
| Logos Global Management LP | 3,743,875 | $46,236,856 | 6.17% |
| MPM BioImpact LLC | 1,857,681 | $22,942,360 | 6.12% |
| Cormorant Asset Management, LP | 4,504,764 | $55,633,835 | 3.24% |
| BVF INC/IL | 9,135,893 | $112,828,279 | 3.04% |
| Vivo Capital, LLC | 1,873,704 | $23,140,244 | 2.54% |
| Altium Capital Management LP | 335,000 | $4,137,250 | 2.16% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 407,801 | $5,036,342 | 1.53% |
| HighVista Strategies LLC | 247,880 | $3,061,318 | 1.42% |
| ACUTA CAPITAL PARTNERS, LLC | 153,007 | $1,889,636 | 1.27% |